Close Menu
    Latest Posts

    Raw milk cheese recalled following multi-state E.coli outbreak: FDA

    September 27, 2026

    BoE using LLM to review meeting minutes

    September 27, 2026

    SEC clears regulatory hurdle as crypto token buybacks hit record $638 million

    September 27, 2026
    Facebook X (Twitter) Instagram
    Trending
    • Raw milk cheese recalled following multi-state E.coli outbreak: FDA
    • BoE using LLM to review meeting minutes
    • SEC clears regulatory hurdle as crypto token buybacks hit record $638 million
    • A $1,000 Investment Split Between Alphabet and Nvidia Will Be Worth This Much by 2030
    • From $6 eggs to $50,000 cars, these charts show how inflation has defined the past 5 years
    • ‘We lived within our means’: I earned $30,000 as a pastor and still retired comfortably. Why don’t you tell people that?
    • Federal Reserve Board – Federal Reserve Board issues enforcement action with former employee of Sandy Spring Bank
    • Fed Moves to Tighten Stablecoin Rules With Two New GENIUS Act Proposals
    Facebook X (Twitter) Instagram
    MoneyLister – Smart Investing & Financial NewsMoneyLister – Smart Investing & Financial News
    Sunday, September 27
    • Home
    • Banking
    • Business
    • Crypto
    • Economy
    • Fintech
    • Investing
    • Markets
    • Stocks
    MoneyLister – Smart Investing & Financial NewsMoneyLister – Smart Investing & Financial News
    Home»Markets»Synopsys Faces a Split Verdict as Shares Drop and Targets Climb
    Markets

    Synopsys Faces a Split Verdict as Shares Drop and Targets Climb

    AdminBy AdminMay 29, 2026No Comments4 Mins Read
    Share Facebook Twitter Pinterest Copy Link LinkedIn Tumblr Email VKontakte Telegram
    AI’s Next Bottleneck May Not Be Chips — But Electricity
    Share
    Facebook Twitter Pinterest Email Copy Link

    is one of the world’s two leading players in the electronic design automation (EDA) industry, along with . The company plays a critical role in advanced semiconductor development. Without top-tier EDA software, creating leading-edge semiconductor designs is nearly impossible.

    Despite Synopsys’s importance, the stock has struggled to gain traction even as the artificial intelligence boom is in full swing. Since the beginning of 2025, Synopsys shares are essentially flat. This comes after the stock dived 8.6% following the company’s latest earnings report.

    Although Synopsys shares fell significantly, analyst price targets moved in the opposite direction—implying a potential opportunity in shares. As the stock continues to underperform, all eyes will be on Synopsys’s Investor Day in September.

    Synopsys Posts Beats and Lifts Guidance, but Ansys Drives Growth

    In its fiscal Q2 2026, Synopsys posted revenue of $2.28 billion. (Note that Synopsys’s fiscal reporting period is slightly ahead of the standard reporting period used by most companies.) This equated to revenue growth of 42% year-over-year (YOY) and beat estimates of $2.25 billion.

    However, the vast majority of this growth was not organic but a product of Synopsys’s Ansys acquisition. Per the earnings call, growth would have been just 3% to 4% YOY excluding Ansys.

    Meanwhile, Synopsys’s adjusted earnings per share (EPS) fell by nearly 9% YOY to $3.35, beating estimates of $3.15 substantially. This figure is tricky as well, as despite adjusted EPS falling, adjusted net income rose by 11% YOY. This difference came as Synopsys’s share count increased by around 23% YOY.

    Synopsys issued a significant number of shares to fund the Ansys deal, as well as directly to NVIDIA, which invested $2 billion in Synopsys. Long story short, Synopsys’s adjusted profit rose, even though it fell on a per-share basis.

    Synopsys also raised its full-year guidance across multiple fronts. Based on midpoint figures:

    • Revenue guidance increased by $65 million to $9.665 billion.
    • Adjusted operating margin guidance increased by 50 basis points to 41%.
    • Adjusted EPS guidance increased by 34 cents to $14.76.
    • Free cash flow guidance increased by $100 million to $2 billion.

    Despite strong postings on many headline metrics, investors likely viewed the fact that Ansys drove nearly all of Synopsys’s growth as a significant negative.

    Analysts Move Targets Up as Shares Fall

    After earnings, MarketBeat tracked several analyst price target upgrades on Synopsys, while not seeing any targets move lower. Among updates for which MarketBeat had previous price target data, the average price target moved up by approximately 7%. This was a near inverse to the 8.6% hit shares took following the report. Still, analysts at BNP Paribas Exane placed an Underweight rating on the stock, while Piper Sandler issued a Hold rating.

    Overall, the average price target among those issued after earnings was approximately $538. This is considerably lower than the MarketBeat consensus price target of $564, indicating that older targets are holding up the consensus figure. The updated $538 average implies moderate upside of about 10%.

    Synopsys and Cadence Shares Are Lagging Big-Time

    It is a bit concerning to see Synopsys underperform the market so significantly. This comes as many semiconductor and AI-related stocks have surged. Since the start of 2025, the has delivered a return above 25%. Meanwhile, the , a commonly used proxy for semiconductor industry performance, is up more than 150%.

    Near-term issues, such as its Ansys acquisition clouding visibility and complications at Intel’s foundry (a key customer), have negatively affected Synopsys. However, Cadence—which has not suffered from the same issues—has also underperformed. Cadence shares are up only around 25% since the start of 2025.

    Thus, the two top EDA stocks are experiencing significant underperformance, even as the industry in which they sit booms. This raises questions about their ability to capture value in the same way they have in the past.

    Synopsys’s Investor Day: Its Key Opportunity to Reinspire Investors

    Despite Synopsys’s poor performance, its products continue to be essential to the semiconductor ecosystem. Additionally, Ansys visibility and Intel’s issues can smooth out over time.

    On its earnings call, Synopsys repeatedly mentioned that it is looking for ways to capture more of the value its products offer customers. This includes new pricing methods for its intellectual property. Synopsys says it will have a few signed customer agreements under this model by the end of the fiscal year.

    Additionally, as AI agents are increasingly used in chip design, Synopsys is working to capture more consumption-based revenue. However, the company said it would give more details about these strategies at its Investor Day at the end of September.

    The firm’s Investor Day will likely be critical to convincing markets that Synopsys can alter its monetization strategies in a way that maximizes the value it captures. Evaluating its plan is critical before materially changing the positive long-term thesis on this stock.

    Original Post

    climb drop faces Shares Split Synopsys Targets Verdict
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email Telegram Copy Link
    Admin
    • Website

    Related Posts

    Investing

    A $1,000 Investment Split Between Alphabet and Nvidia Will Be Worth This Much by 2030

    September 27, 2026
    Markets

    From $6 eggs to $50,000 cars, these charts show how inflation has defined the past 5 years

    September 27, 2026
    Markets

    Appeals court rules states can regulate sports prediction markets

    September 26, 2026
    Markets

    3 things Micron investors need to watch as the stakes get higher

    September 25, 2026
    Markets

    TransUnion Says CFO Todd Cello To Step Down By Year-end; Backs Q3, FY26 Outlook

    September 24, 2026
    Markets

    10-year Treasury yields stay near 5%, what would trigger the next break higher?

    September 22, 2026
    Add A Comment
    Leave A Reply Cancel Reply

    Top Posts

    Raw milk cheese recalled following multi-state E.coli outbreak: FDA

    September 27, 2026

    BoE using LLM to review meeting minutes

    September 27, 2026

    SEC clears regulatory hurdle as crypto token buybacks hit record $638 million

    September 27, 2026

    A $1,000 Investment Split Between Alphabet and Nvidia Will Be Worth This Much by 2030

    September 27, 2026
    Latest Posts

    Subscribe to News

    Get the latest sports news from NewsSite about world, sports and politics.

    About Us

    Welcome to MoneyLister.com — your trusted source for reliable insights in the world of finance, investing, and digital assets.

    At MoneyLister, our mission is simple: to make complex financial topics easy to understand and accessible to everyone. Whether you're a beginner exploring cryptocurrency, an investor tracking the stock market, or a professional staying updated on global business trends, we provide clear, informative, and up-to-date content to help you stay ahead.

    Facebook X (Twitter) Instagram Pinterest YouTube
    Latest Posts

    Raw milk cheese recalled following multi-state E.coli outbreak: FDA

    September 27, 2026

    BoE using LLM to review meeting minutes

    September 27, 2026

    SEC clears regulatory hurdle as crypto token buybacks hit record $638 million

    September 27, 2026
    Recent Posts
    • Raw milk cheese recalled following multi-state E.coli outbreak: FDA
    • BoE using LLM to review meeting minutes
    • SEC clears regulatory hurdle as crypto token buybacks hit record $638 million
    • A $1,000 Investment Split Between Alphabet and Nvidia Will Be Worth This Much by 2030
    • From $6 eggs to $50,000 cars, these charts show how inflation has defined the past 5 years
    © 2026 moneylister. Designed by Pro.
    • About Us
    • Contact Us
    • Privacy Policy
    • Terms and Conditions
    • Disclaimer

    Type above and press Enter to search. Press Esc to cancel.